Ontario takes aim at painkiller abuse

Silversides, Ann
October 2009
CMAJ: Canadian Medical Association Journal;10/13/2009, Vol. 181 Issue 8, pE141
Academic Journal
The article offers information on two committees formed in Ontario to control the misuse of prescription painkillers and to reduce the rising number of Ontarians seeking treatment for opioid addiction. It mentions that committees including the Opioid Public Policy Project and the Narcotics Advisory Panel have been introduced in the state early in the year 2009. It informs that the committees were created after a study revealed that Ontario is becoming a hub of opioid use in Canada.


Related Articles

  • FDA Panel Wants Stronger REMS for Opioids.  // BioWorld Today;7/26/2010, Vol. 21 Issue 142, p5 

    The article reports on the decision of a U.S. Food and Drug Administration (FDA) advisory panel to reject a classwide risk evaluation and mitigation strategy (REMS) plan proposed by the agency for extended-release and long-acting opioids. According to the panel, the plan was too weak to prevent...

  • THE Rx FOR AVOIDING ADDICTION. Stewart, Julie // Men's Health;Jul/Aug2012, Vol. 27 Issue 6, p116 

    The article suggests how one can avoid getting addicted to opioids which includes asking doctor to watch for signs of abuse, monitoring motives to take them like depression and anxiety and taking them exactly as prescribed.

  • Pharmacovigilance & Regulatory News.  // Reactions Weekly;1/19/2013, Issue 1435, p4 

    This section offers news briefs on pharmaceutical policies including the draft guidance issued by the U.S. Food and Drug Administration for the development of abuse-deterrent opioids and progress made by Australia and New Zealand in their joint therapeutic products regulatory scheme.

  • Purdue Targets Rx Painkiller Abuse.  // Chain Drug Review;9/28/2015, Vol. 37 Issue 15, p100 

    The article reports on the web portal launched by painkiller maker Purdue Pharma LP which aid in reducing opioid abuse and misuse.

  • Study Eyes 'Prescription Opioid Crisis'.  // Chain Drug Review;10/26/2015, Vol. 37 Issue 17, p98 

    The article reports on the study led by doctor Beth Han in Rockville, Maryland which aims to address the crisis in prescription opioid which uses the survey data on people who reported nonmedical use and overdose deaths from 2003-2013.

  • FDA panels vote against plan to reduce opioid abuse.  // Medical Economics;8/20/2010, Vol. 87 Issue 16, p49 

    The article reports on the decision of two U.S. Food and Drug Administration (FDA) advisory panels to vote against a plan that would reduce abuse of long-acting and extended-release opioid drugs.

  • Multiple Ligands in Opioid Research. Ballet, Steven; Pietsch, Markus; Abell, Andrew D. // Protein & Peptide Letters;Jul2008, Vol. 15 Issue 7, p668 

    The observation in 1979 that opioid receptors interact, led to the design of bivalent ligands in an attempt to improve selectivity and affinity towards the different subtypes (i.e. μ, δ and κ). Dimers of monovalent "parent" opioid structures have been evaluated and include: (a)...

  • Pharmacist's role in opiod use.  // Pharmacy Today;Jan2013, Vol. 19 Issue 1, p16 

    The article discusses a 2012 meeting hosted by the American Pharmacists Association (APhA) and funded by grants from the Purdue Pharma LP, Endo Pharmaceuticals Inc., and Teva Pharmaceuticals Srl.

  • NY AG and Purdue Pharma agree to fight opiod habit. Fallon, Bill // Fairfield County Business Journal;8/31/2015, Vol. 51 Issue 35, p2 

    The article reports on the agreement between New York State Attorney General (AG) Eric T. Schneiderman and Stamford, Connecticut-based Purdue Pharma LP which aims to restrict the promotion and marketing of opioid to health care providers to prevent its illegal and abusive use in pain treatment.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics